title: [Use of defibrotide in the treatment of Raynaud's phenomenon associated with progressive systemic sclerosis or essential mixed cryoglobulinemia].
authors.forename: G
authors.initials: G
authors.lastname: Ranieri
authors.forename: V
authors.initials: V
authors.lastname: De Mitrio
authors.forename: M
authors.initials: M
authors.lastname: Petronelli
authors.forename: A
authors.initials: A
authors.lastname: Ancona
authors.forename: F
authors.initials: F
authors.lastname: Dammacco
mesh_terms: D000293:Adolescent; D000328:Adult; D003449:Cryoglobulinemia / Q000150:complications*; D004341:Drug Evaluation; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D008875:Middle Aged; D011089:Polydeoxyribonucleotides / Q000627:therapeutic use*; D011928:Raynaud Disease / Q000150:complications / Q000188:drug therapy*; D012595:Scleroderma, Systemic / Q000150:complications*
chemical_list: D005343:Fibrinolytic Agents; D011089:Polydeoxyribonucleotides; C036901:defibrotide
vernacular_title: Impiego del defibrotide nel trattamento del fenomeno di Raynaud associato a sclerosi sistemica progressiva o crioglobulinemia mista essenziale.